Gain Therapeutics, Inc(NASDAQ:GANX) 
Gain Therapeutics, Inc. is a redefining drug discovery company with its proprietary target identification platform. It focuses on identifying and optimizing allosteric binding sites and is unlocking new treatment options for disorders characterized by protein misfolding. The company was founded in 2...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.72
H 1.80
L 1.56
C 1.65
V 454,753
10EMA 1.65
20EMA 1.65
60EMA 1.65
120EMA 1.65
250EMA 1.65